Back to Browse Journals » International Journal of Women's Health » Volume 1

Treating dyspareunia caused by vaginal atrophy: a review of treatment options using vaginal estrogen therapy

Authors SA Kingsberg, S Kellogg, M Krychman

Published Date August 2009 Volume 2009:1 Pages 105—111

DOI http://dx.doi.org/10.2147/IJWH.S4872

Published 20 August 2009

SA Kingsberg¹, S Kellogg², M Krychman³

1University Hospitals Case Medical Center, Case Western Reserve University Cleveland OH, USA; 2The Pelvic and Sexual Health Institute of Philadelphia, Drexel University College of Medicine, Philadelphia, USA; 3Southern California Center for Sexual Health and Survivorship Medicine, Newport Beach, CA, USA

Abstract: Vulvovaginal atrophy (VVA) and dryness are common symptoms of the decline in endogenous production of estrogen at menopause and often result in dyspareunia. Yet while 10% to 40% of women experience discomfort due to VVA, it is estimated that only 25% seek medical help. The main goals of treatment for vaginal atrophy are to improve symptoms and to restore vaginal and vulvar anatomic changes. Treatment choices for postmenopausal dyspareunia resulting from vulvovaginal atrophy will depend on the underlying etiology and might include individualized treatment. A number of forms of vaginal estrogen and manner of delivery are currently available to treat moderate to severe dyspareunia caused by VVA. They all have been shown to be effective and are often the preferred treatment due to the targeted efficacy for urogenital tissues while resulting in only minimal systemic absorption. Both healthcare professionals and patients often find it difficult to broach the subject of sexual problems associated with VVA. However, with minimal effort to initiate a conversation about these problems, healthcare providers can provide useful information to their postmenopausal patients in order to help them each choose the optimal treatment for their needs and symptoms.

Keywords: dyspareunia, postmenopausal vulvovaginal atrophy, vaginal estrogen therapy

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Factors associated with inadequate diagnosis of COPD: On-Sint cohort analysis

Fernández-Villar A, López-Campos JL, Represas Represas C, Marín Barrera L, Leiro Fernández V, López Ramírez C, Casamor R

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:961-967

Published Date: 18 May 2015

Photoactive TiO2 antibacterial coating on surgical external fixation pins for clinical application

Villatte G, Massard C, Descamps S, Sibaud Y, Forestier C, Awitor KO

International Journal of Nanomedicine 2015, 10:3367-3375

Published Date: 6 May 2015

Red cell distribution width and neurological scoring systems in acute stroke patients

Kara H, Degirmenci S, Bayir A, Ak A, Akinci M, Dogru A, Akyurek F, Kayis SA

Neuropsychiatric Disease and Treatment 2015, 11:733-739

Published Date: 18 March 2015

Stem cell tracking using iron oxide nanoparticles

Bull E, Madani SY, Sheth R, Seifalian A, Green M, Seifalian AM

International Journal of Nanomedicine 2014, 9:1641-1653

Published Date: 31 March 2014

Analysis of in situ and ex vivo αVß3 integrin expression during experimental carotid atherogenesis

Yao Y, Jiang Y, Sheng Z, Zhang Y, An Y, Yan F, Ma G, Liu N, Teng G, Cheng Z

International Journal of Nanomedicine 2012, 7:641-649

Published Date: 8 February 2012

Nanoparticles of carbon allotropes inhibit glioblastoma multiforme angiogenesis in ovo

Grodzik M, Sawosz E, Wierzbicki M, Orlowski P, Hotowy A, Niemiec T, Szmidt M, Mitura K, Chwalibog A

International Journal of Nanomedicine 2011, 6:3041-3048

Published Date: 25 November 2011

Erratum - Intracellular heavy metal nanoparticle storage

Iannitti T, Capone S, Gatti A, et al

International Journal of Nanomedicine 2011, 6:239-240

Published Date: 26 January 2011

Tinidazole in the treatment of bacterial vaginosis

Nicola R Armstrong, Janet D Wilson

International Journal of Women's Health 2009, 1:59-65

Published Date: 25 June 2009